The focus of this research is to see if a person can complete the immunisation course by receiving two distinct vaccine doses, one of Covishield and one of Covaxin.
Cipla on Tuesday received the approval from the Drugs Controller General of India (DCGI) to import Moderna’s coronavirus vaccine for restricted emergency use in India.